Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours
Authors
Chiramel, JaseelaAlmond, Rose
Slagter, A
Khan, Adeel
Wang, Xin
Lim, Kok Haw Jonathan
Frizziero, Melissa
Chakrabarty, Bipasha
Minicozzi, Annamaria
Lamarca, Angela
Mansoor, Was
Hubner, Richard A
Valle, Juan W
McNamara, Mairead G
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.Issue Date
2020
Metadata
Show full item recordCitation
Chiramel J, Almond R, Slagter A, Khan A, Wang X, Lim KHJ, et al. Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours. World J Clin Oncol. 2020;11(4):205-16.Journal
World Journal of Clinical OncologyDOI
10.5306/wjco.v11.i4.205PubMed ID
32355642Additional Links
https://dx.doi.org/ 10.5306/wjco.v11.i4.205Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.5306/wjco.v11.i4.205
Scopus Count
Collections
Related articles
- Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.
- Authors: Daskalakis K, Wedin M, Tsoli M, Kogut A, Srirajaskanthan R, Sarras K, Kattiparambil S, Giovos G, Weickert MO, Kos-Kudla B, Kaltsas G
- Issue date: 2022 Nov
- Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
- Authors: Broadbent R, Wheatley R, Stajer S, Jacobs T, Lamarca A, Hubner RA, Valle JW, Amir E, McNamara MG
- Issue date: 2021 Dec
- Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
- Authors: Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK
- Issue date: 2019 Aug
- Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
- Authors: DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC, other members of the United States Neuroendocrine Tumor Study Group
- Issue date: 2019 Nov
- Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.
- Authors: Slagter AE, Ryder D, Chakrabarty B, Lamarca A, Hubner RA, Mansoor W, O'Reilly DA, Fulford PE, Klümpen HJ, Valle JW, McNamara MG
- Issue date: 2016 Sep